Pursuant to section 29 of the Danish Securities Trading Act, cf. section 4(viii), cf. section 5(3), of the executive order on major shareholders, Coloplast A/S announces that the company’s Board of Directors has received proxies from a number of shareholders to vote on their behalf at the annual general meeting to be held on 1 December 2010.

Coloplast’s Board of Directors has received proxies as a result of which the Board of Directors has at its disposal votes equivalent to more than 5% of the total voting rights at the annual general meeting.

Accordingly, as of today, the Board of Directors has proxies in respect of 8.41% of the voting rights and of the company’s total share capital.

After the close of the annual general meeting on 1 December 2010, the Board of Directors’ authority to vote under the proxies received will lapse. 

Lene Skole
Executive Vice President, CFO



Download the announcement here.